Opioid Induces Increased DNA Damage in Prefrontal Cortex and Nucleus Accumbens
Overview
Pharmacology
Psychology
Social Sciences
Affiliations
Opioid use disorder (OUD) is a chronic disease characterized by compulsive opioid taking and seeking, affecting millions of people worldwide. The high relapse rate is one of the biggest challenges in treating opioid addiction. However, the cellular and molecular mechanisms underlying relapse to opioid seeking are still unclear. Recent studies have shown that DNA damage and repair processes are implicated in a broad spectrum of neurodegenerative diseases as well as in substance use disorders. In the present study, we hypothesized that DNA damage is related to relapse to heroin seeking. To test our hypothesis, we aim to examine the overall DNA damage level in prefrontal cortex (PFC) and nucleus accumbens (NAc) after heroin exposure, as well as whether manipulating DNA damage levels can alter heroin seeking. First, we observed increased DNA damage in postmortem PFC and NAc tissues from OUD individuals compared to healthy controls. Next, we found significantly increased levels of DNA damage in the dorsomedial PFC (dmPFC) and NAc from mice that underwent heroin self-administration. Moreover, increased accumulation of DNA damage persisted after prolonged abstinence in mouse dmPFC, but not in NAc. This persistent DNA damage was ameliorated by the treatment of reactive oxygen species (ROS) scavenger N-acetylcysteine, along with attenuated heroin-seeking behavior. Furthermore, intra-PFC infusions of topotecan and etoposide during abstinence, which trigger DNA single-strand breaks and double-strand breaks respectively, potentiated heroin-seeking behavior. These findings provide direct evidence that OUD is associated with the accumulation of DNA damage in the brain (especially in the PFC), which may lead to opioid relapse.
Logan R, Shelton M, Horan N, Xue X, Maturin L, Eacret D Res Sq. 2024; .
PMID: 39399686 PMC: 11469374. DOI: 10.21203/rs.3.rs-5006061/v1.
Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder.
Phan B, Ray M, Xue X, Fu C, Fenster R, Kohut S Nat Commun. 2024; 15(1):878.
PMID: 38296993 PMC: 10831093. DOI: 10.1038/s41467-024-45165-7.